Tetra Bio-Pharma Inc. (TSXV: TBP) (OTCQB: TBPMF), is a bio-pharmaceutical company engaged in cannabinoid-derived drug discovery and development. The company provides an update on the development of its ARDS-003 intravenous drug product for the potential treatment of cytokine release syndrome […]





